SS-31 (Elamipretide) Research Peptide: A Mitochondria-Targeted Tetrapeptide
A research overview of SS-31 (elamipretide) — a mitochondria-targeted, cardiolipin-binding tetrapeptide studied for its effects on mitochondrial energetics and oxidative stress — covering background, mechanism, published studies, and storage. For laboratory research use only.
SS-31, also known as elamipretide, is a synthetic aromatic-cationic tetrapeptide (D-Arg-2',6'-dimethyltyrosine-Lys-Phe-NH2) that concentrates in the inner mitochondrial membrane, where it binds the phospholipid cardiolipin. In laboratory and animal models it has been studied for its ability to stabilize mitochondrial structure, support electron transport efficiency, and reduce the production of reactive oxygen species (ROS). This article summarizes the research background, proposed mechanism, published literature, and handling guidance for SS-31 as a research compound. All information is provided strictly for in-vitro and laboratory research use only.
What Is SS-31?
SS-31 belongs to the Szeto-Schiller (SS) family of cell-permeable peptides first characterized in the early-to-mid 2000s. Unlike many antioxidants that distribute broadly through a cell, SS-31 partitions selectively into mitochondria independent of membrane potential, reaching concentrations in the inner membrane far above those in the surrounding cytosol. Its clinical-stage counterpart, elamipretide, has been evaluated by Stealth BioTherapeutics across a range of conditions involving mitochondrial dysfunction. As a freshness marker for readers tracking the field: in September 2025 the U.S. FDA granted elamipretide accelerated approval (marketed as Forzinity) to improve muscle strength in patients with Barth syndrome, a rare genetic disorder of cardiolipin remodeling — the first disease-specific therapy for that condition. That regulatory milestone concerns a defined patient population and is noted here only as scientific context; it does not describe or endorse any use of the research compound sold on this page.
Mechanism of Action
Cardiolipin is a phospholipid found almost exclusively in the inner mitochondrial membrane, where it helps organize the respiratory chain complexes and cristae architecture. Research indicates that SS-31 associates with cardiolipin through electrostatic and hydrophobic interactions, helping to preserve the curvature of cristae membranes and the assembly of respiratory supercomplexes. By stabilizing this environment, SS-31 has been reported to improve the efficiency of electron transport and adenosine triphosphate (ATP) synthesis while limiting electron leak that generates ROS.
Key proposed effects reported in models
Across published studies, investigators have described SS-31 as: binding cardiolipin on the inner mitochondrial membrane; supporting respiratory chain and ATP output; reducing mitochondrial ROS and downstream oxidative damage; and improving mitochondrial quality-control processes such as mitophagy. Because these observations come from cell cultures and animal models, they characterize the compound's biochemical behavior rather than any outcome in humans.
Published Research Overview
A substantial peer-reviewed literature has examined SS-31/elamipretide in preclinical systems:
- A foundational study in *Aging Cell* (2013) reported that a mitochondria-targeted peptide rapidly improved mitochondrial energetics and skeletal-muscle performance in aged mice, linking cardiolipin binding to functional recovery.
- Work in *Free Radical Biology and Medicine* (2019) found that SS-31 restored redox homeostasis and improved exercise tolerance in aged mice without increasing mitochondrial content, pointing to improved mitochondrial quality rather than quantity.
- A study in *GeroScience* (2018) reported that the peptide rescued neurovascular coupling responses and cerebrovascular endothelial function and improved cognition in aged mice.
- A later *GeroScience* (2023) analysis described how elamipretide improved ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT), offering a more granular view of its bioenergetic effects.
- Research on INS-1 β-cells reported that elamipretide promoted mitophagosome formation and prevented its reduction under nutrient-excess conditions, implicating mitochondrial quality control.
- A 2025 *Drugs* "First Approval" review summarized the compound's structure, mechanism, and regulatory status following its accelerated approval.
Full citations with links appear in the References section below. This body of evidence is drawn largely from in-vitro and animal models; broad human clinical data outside specific rare-disease trials remain limited.
Storage & Handling
Dynamite Research Peptides supplies SS-31 in lyophilized (freeze-dried) form. Store the powder at -20°C or below, protected from light and moisture. Reconstitute immediately before use with a sterile solvent as indicated on the Certificate of Analysis (COA), keep reconstituted material refrigerated, and avoid repeated freeze-thaw cycles that can degrade peptide integrity. Handle with appropriate personal protective equipment in a well-ventilated laboratory setting.
Conclusion
SS-31 is a useful tool compound for studying mitochondrial bioenergetics, cardiolipin biology, oxidative stress, and mitochondrial quality control in laboratory models. Our SS-31 is high-purity, third-party tested, and ships with a COA so experimental results stay reliable and reproducible.
Frequently Asked Questions
What is SS-31 (elamipretide)? It is a synthetic mitochondria-targeted tetrapeptide that binds cardiolipin in the inner mitochondrial membrane and has been studied in cell and animal models for its effects on mitochondrial energetics and reactive oxygen species.
How does SS-31 differ from a general antioxidant? Rather than acting throughout the cell, SS-31 concentrates selectively in mitochondria independent of membrane potential and associates with cardiolipin, so research has focused on its effects at the site where oxidative phosphorylation occurs.
What is the purity level of Dynamite Research Peptides' SS-31? Our SS-31 is typically 99%+ pure, verified by HPLC analysis. Detailed purity data is provided on the Certificate of Analysis (COA) included with each product.
What research applications is SS-31 suitable for? It is used in studies of mitochondrial function, cardiolipin and membrane biology, oxidative stress, cellular bioenergetics, and mitochondrial quality-control pathways such as mitophagy.
All products are for research use only — not for human or animal consumption, and not for diagnostic or therapeutic use.
References
- Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice — Aging Cell, 2013. Source
- Improving mitochondrial function with SS-31 reverses age-related redox stress and improves exercise tolerance in aged mice — Free Radical Biology and Medicine, 2019. Source
- Treatment with the mitochondrial-targeted antioxidant peptide SS-31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice — GeroScience, 2018. Source
- The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria by increasing uptake through the adenine nucleotide translocator (ANT) — GeroScience, 2023. Source
- Elamipretide Promotes Mitophagosome Formation and Prevents Its Reduction Induced by Nutrient Excess in INS-1 β-cells — Journal of Molecular Biology, 2019. Source
- Elamipretide: First Approval — Drugs, 2025. Source
Researching this compound? See where to buy research peptides — what to look for in third-party testing, purity, and a Certificate of Analysis.
For research and educational use only. Not medical advice. Compounds discussed are for laboratory research use only and are not for human or veterinary consumption.